Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Aligos Therapeutics (ALGS) Return on Assets (2021 - 2025)

Historic Return on Assets for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to 0.71%.

  • Aligos Therapeutics' Return on Assets rose 700.0% to 0.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 1.18% for FY2024, which is 6000.0% down from last year.
  • Aligos Therapeutics' Return on Assets amounted to 0.71% in Q3 2025, which was up 700.0% from 0.52% recorded in Q2 2025.
  • In the past 5 years, Aligos Therapeutics' Return on Assets registered a high of 0.48% during Q1 2025, and its lowest value of 1.66% during Q4 2024.
  • Over the past 5 years, Aligos Therapeutics' median Return on Assets value was 0.64% (recorded in 2022), while the average stood at 0.72%.
  • In the last 5 years, Aligos Therapeutics' Return on Assets plummeted by -9200bps in 2024 and then surged by 2300bps in 2025.
  • Over the past 5 years, Aligos Therapeutics' Return on Assets (Quarter) stood at 0.51% in 2021, then fell by -20bps to 0.62% in 2022, then fell by -20bps to 0.74% in 2023, then crashed by -124bps to 1.66% in 2024, then soared by 57bps to 0.71% in 2025.
  • Its last three reported values are 0.71% in Q3 2025, 0.52% for Q2 2025, and 0.48% during Q1 2025.